首页 > 市场调查报告书 > 製药

欧洲智慧生命科学製造市场预测至 2028 年 - 区域分析 - 按组件（解决方案和服务）、技术、应用（製药、生物製药和医疗器材）

市场调查报告书

商品编码

1393985

欧洲智慧生命科学製造市场预测至 2028 年 - 区域分析 - 按组件（解决方案和服务）、技术、应用（製药、生物製药和医疗器材）

Europe Smart Life Sciences Manufacturing Market Forecast to 2028 - Regional Analysis - by Component (Solutions and Services), Technology, Application (Pharma, Bio-Pharma, and Medical Device)

出版日期: 2023年10月11日 | 出版商:

The Insight Partners | 英文 195 Pages | 订单完成后即时交付

价格

简介目录图表

欧洲智慧生命科学製造市场预计将从2023年的56.7919亿美元成长到2033年的220.5287亿美元。预计2023年至2033年CAGR为14.5%。

製药 4.0 的采用不断增加，推动欧洲智慧生命科学製造市场

科技在医疗保健领域一直发挥着重要作用，其中与肿瘤学、神经学和免疫学等其他领域相比，生物技术产业是资料分析领域最新技术进步中受益最大的领域。新兴的资料科学技术也有助于生物技术产业的发展。生物技术实验室的主要作用是生物体分析、新药研究等。

现代资料分析工具使生物技术研究人员能够创建预测分析模型，并最终使他们了解实现其预期目的和目标的最有效方法。大资料、人工智慧、虚拟实境、资料视觉化和资料安全是生物技术实验室常用的技术。 Novozymes 是一家领先的生物技术公司，总部位于丹麦哥本哈根郊外的 Bagsværd，它采用了资料视觉化工具 Tableau，彻底改变了其资料分析和协作方法。 Tableau 帮助 Novozymes 将报表时间缩短了 90% 以上。它还协助公司部门内的策略决策，如销售、原材料采购、规划和财务。此外，Tableau 还允许 Novozymes 的销售人员与客户分享关键见解，从而建立关係并提高收入绩效。

阿斯特捷利康 (AstraZeneca, plc) 是一家英国-瑞典跨国製药和生物技术公司，利用资料和技术来最大限度地缩短发现和交付潜在新药的时间。该公司的研发部门嵌入了资料科学和人工智慧功能，使科学家能够突破科学的界限，提供改变生活的药物。他们将人工智慧应用于从目标识别到临床试验的整个发现和开发过程，以发现指导药物发现和开发过程的新见解。

Atomwise 拥有在小分子药物发现中使用人工智慧的专业知识。 2021 年 12 月，该公司宣布其新兴合资公司的投资组合不断扩大，研究计画涵盖肿瘤学、免疫学、传染病、神经科学和凝血障碍。在传染病领域，该公司宣布增加与世界RNA病毒专家Nito Panganiban新成立的合资公司vAirus。该合资企业将使用基于人工智慧的筛选来寻找小分子化合物，作为针对黄病毒的新型广谱抗病毒药物。电子健康记录 (eHR) 等整合式巨量资料工具可以让医疗保健专业人员轻鬆获得全面的患者健康记录，即使有关患者健康的资讯来自分散的来源。巨量资料支持的基因研究的其他进展可能会在对抗镰状细胞疾病、囊性纤维化和血友病等单基因疾病方面取得巨大进展。此类研究也可用于开发针对精神疾病和心臟病等复杂疾病的改良治疗和预防策略。

欧洲智慧生命科学製造市场概况

欧洲是智慧生命科学製造的已开发地区之一，工业4.0是德国政府于2011年启动的第四次革命，描述製造过程中的数位化变革。国际製药工程学会（ISPE）于2017年推出Pharma 4.0，全面推动药厂数位化技术的实施。由于智慧製造的高度实施，该地区智慧生命科学製造发生了重大变化，生命科学製造商之间的合作可能会在未来几年推动欧洲市场的成长。 2020 年 5 月，欧洲最大的製药製造商之一 Adamed Group 与 Predica 合作部署 Microsoft Azure 云端平台，包括安全性、资料分析、机器学习和应用程式开发。 Predica 设计并开发了一个基于 Azure资料服务和 Power BI 的完全可扩展平台，帮助 Adamed 产生自动预测并优化其供应链和行销决策。此外，2022 年，来自葡萄牙的合约开发和製造组织 (CDMO) 之一 Hovione 与 GEA 合作推进连续压片。此次策略合作将 GEA 的工程专业知识与 Hovione 的开发和製造经验结合，双方承诺合作加速连续压片技术的采用。

COVID-19 大流行增加了智慧製造技术的采用和实施，特别是在呼吸机、病床、药物和疫苗的生产方面。这导致该地区医疗器材和药品生产和审批的监管政策发生重大变化。欧洲议会已用法规取代了医疗器材指令。由于疫情的影响，製造商修改了该地区法规的适用规定。对于低风险器械，从指令到监管的过渡期延长至2027年5月，对于中风险器械，该过渡期延长至2026年5月。此外，高风险器械的过渡期延长至2025年5月。医疗器械中的数位自动化有助于遵守法规并轻鬆处理审批，从而减少审批时间并有助于及时推出产品。不断变化的监管环境、生命科学製造中数位技术的高采用率以及市场参与者之间不断加强的合作预计将在预测期内增强欧洲智慧生命科学製造市场的成长。

欧洲智慧生命科学製造市场收入及 2033 年预测（百万美元）

欧洲智慧生命科学製造市场区隔

欧洲智慧生命科学製造市场分为技术、组件、应用和国家。

根据组件，欧洲智慧生命科学製造市场分为解决方案和服务。 2023年，解决方案领域在欧洲智慧生命科学製造市场中占有更大份额。

根据技术，欧洲智慧生命科学製造细分市场分为AR/VR系统、物联网（IoT）、人工智慧（AI）、网路安全、大数据等。 2023年，物联网领域在欧洲智慧生命科学製造市场中占有最大份额。

根据应用，欧洲智慧生命科学製造市场分为製药、生物製药和医疗器材。 2023年，医疗器材领域在欧洲智慧生命科学製造市场中占最大份额。

依国家/地区划分，欧洲智慧生命科学製造市场分为德国、法国、义大利、西班牙、英国和欧洲其他地区。 2023年，德国在欧洲智慧生命科学製造市场占据主导地位。

ABB Ltd、Bosch Rexroth AG、艾默生电气公司、Fortinet Inc、通用电气公司、霍尼韦尔国际公司、国际商业机器公司、罗克韦尔自动化公司、西门子公司和Sophos Ltd 是欧洲智慧生命科学领域的一些领先公司製造市场。

市场驱动因素
- 製药 4.0 的采用率不断上升
- 生物技术实验室越来越多地使用技术
市场限制
- 存在技能差距和需要高额初始投资
市场机会
- 人工智慧在癌症研究的应用
- 智慧工厂采用虚拟实境
未来的趋势
- 连接到资料孤岛
- 区块链的使用
- 边缘运算
- 预测性维护
- 基于愿景的品质管理
- 智慧工厂趋势
- 工业5.0的出现
驱动因素和限制因素的影响分析

第 6 章：欧洲智慧生命科学製造市场 - 欧洲分析

概述

第 7 章：欧洲智慧生命科学製造市场分析 - 按组成部分

概述
欧洲智慧生命科学製造市场，按组成部分（2022 年和 2033 年）
解决方案
服务

第 8 章：欧洲智慧生命科学製造市场分析 - 按技术

概述
欧洲智慧生命科学製造市场，依技术划分（2022 年和 2033 年）
AR/VR系统
物联网 (IOT)
人工智慧
网路安全
大数据
其他的

第 9 章：欧洲智慧生命科学製造市场分析 - 按最终用途产业

概述
欧洲智慧生命科学製造市场，依最终用途产业划分（2022 年和 2033 年）
製药公司
生物製药
医疗装置

第 10 章：欧洲智慧生命科学製造市场分析 - 按国家/地区

欧洲智慧生命科学製造市场概况

第 11 章：产业格局

概述
市场计划、扩张和策略发展
新产品/功能开发
併购
协议、合作和合资企业

第 12 章：公司简介

ABB Ltd
Bosch Rexroth AG
Emerson Electric Co
Fortinet Inc
General Electric Co
Honeywell International Inc
International Business Machines Corp
Rockwell Automation Inc
Siemens AG
Sophos Ltd.

第 13 章：附录

关于 Insight Partners
词索引

简介目录图表

Product Code: BMIRE00028923

The Europe smart life sciences manufacturing market is expected to grow from US$ 5,679.19 million in 2023 to US$ 22052.87 million by 2033. It is estimated to grow at a CAGR of 14.5% from 2023 to 2033.

Rising Adoption of Pharma 4.0 Fuel Europe Smart Life Sciences Manufacturing Market

Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the biotechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by biotechnology laboratories.

Modern data analytics tools have allowed biotechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Novozymes, a leading biotechnology company headquartered in Bagsværd, just outside of Copenhagen, Denmark, has adopted Tableau, a data visualization tool, which revolutionized its approach to data analysis and collaboration. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company's departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes' sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.

AstraZeneca, plc, a British-Swedish multinational pharmaceutical and biotechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process.

Atomwise has expertise in using AI in small-molecule drug discovery. In December 2021, the company announced its growing portfolio of emerging joint venture companies, with research programs spanning oncology, immunology, infectious disease, neuroscience, and clotting disorders. In the area of infectious disease, the company announced the addition of vAirus, a newly formed joint venture company with world RNA-virus expert Nito Panganiban. The joint venture will use AI-based screening to find small molecule compounds to act as novel broad-spectrum antivirals against flaviviruses. Integrated big data tools such as electronic health records (eHR) can make it easy for healthcare professionals to obtain a comprehensive patient health record, even if information regarding their health originates from scattered sources. Other advances in genetic research backed by big data could lead to dramatic progress in the fight against single-gene disorders, such as sickle cell disease, cystic fibrosis, and hemophilia. This type of research can also be employed to develop improved treatments and prevention strategies for complex conditions such as mental illness and heart disease.

Europe Smart Life Sciences Manufacturing Market Overview

Europe is one of the developed regions for smart life sciences manufacturing, and Industry 4.0 is the fourth revolution started in 2011 by the German government to describe the digital changes in the manufacturing process. The International Society of Pharmaceutical Engineering (ISPE) introduced Pharma 4.0 in 2017, which takes a holistic approach to the implementation of digital technology in pharmaceutical enterprises. The region has seen significant changes in smart life sciences manufacturing owing to the high implementation of smart manufacturing and collaborations among life sciences manufacturers are likely to propel the market growth in Europe in the coming years. In May 2020, Adamed Group, one of the largest pharmaceutical manufacturers in Europe, partnered with Predica for the deployment of Microsoft Azure cloud platform, including security, data analytics, machine learning, and app development. Predica designed and developed a fully extensible platform based on Azure data services and Power BI that helped Adamed generate automated forecasts and optimize its supply chain and marketing decisions. Additionally, in 2022, Hovione, one the Contract Development and Manufacturing Organization (CDMO) from Portugal, collaborated with GEA to advance continuous tableting. This strategic collaboration combines GEA's engineering expertise with Hovione's development and manufacturing experience, and both parties commit to partner to accelerate the adoption of continuous tableting technology.

COVID-19 pandemic has increased the adoption and implementation of smart manufacturing technologies, especially for the production of ventilators, hospital beds, drugs, and vaccines. This led to a significant change in the regulatory policies of the region for the production and approval of medical devices and drugs. The European Parliament has replaced medical device directives with regulations. Owing to the pandemic, the manufacturers have amended provisions for the application of regulations in the region. For low-risk devices, the transition period from directive to regulation is extended until May 2027, and for moderate-risk devices, the period is extended until May 2026. Also, the transition period for high-risk devices is extended until May 2025. Digital automation in medical devices helps comply with the regulation and easily process approval, which reduces the approval time and assists in timely product launches. The changing regulatory scenario, high adoption rate of digital technology in life sciences manufacturing, and rising collaborations among market players are expected to augment the Europe smart life sciences manufacturing market growth in Europe during the forecast period.

Europe Smart Life Sciences Manufacturing Market Revenue and Forecast to 2033 (US$ Million)

Europe Smart Life Sciences Manufacturing Market Segmentation

The Europe smart life sciences manufacturing market is segmented into technology, component, application, and country.

Based on component, the Europe smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the Europe smart life sciences manufacturing Market in 2023.

Based on technology, the Europe smart life sciences manufacturing market segment is categorized into AR/VR Systems, Internet of things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of Things segment held the largest share of the Europe smart life sciences manufacturing market in 2023.

Based on application, the Europe smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The medical devices segment held the largest share of the Europe smart life sciences manufacturing market in 2023.

Based on country, the Europe smart life sciences manufacturing market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the Europe smart life sciences manufacturing market in 2023.

ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the Europe smart life sciences manufacturing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Smart Life Sciences Manufacturing Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe Smart Life Sciences Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Smart Life Sciences Manufacturing Market - By Component
- 1.3.2 Europe Smart Life Sciences Manufacturing Market - By Technology
- 1.3.3 Europe Smart Life Sciences Manufacturing Market - By End Use Industry
- 1.3.4 Europe Smart Life Sciences Manufacturing Market - By Country

2. Europe Smart Life Sciences Manufacturing Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Smart Life Sciences Manufacturing Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion

5. Europe Smart Life Sciences Manufacturing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Adoption of Pharma 4.0
- 5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
5.2 Market Restraints
- 5.2.1 Presence of Skill Gap and Need for High Initial Investment
5.3 Market Opportunities
- 5.3.1 Use of Artificial Intelligence in Cancer Research
- 5.3.2 Adoption of Virtual Reality in Smart Factory
5.4 Future Trends
- 5.4.1 Connection to Data Silos
- 5.4.2 Usage of Blockchain
- 5.4.3 Edge Computing
- 5.4.4 Predictive Maintenance
- 5.4.5 Vision-Based Quality Management
- 5.4.6 Smart Factory Trends
- 5.4.7 Emergence of Industry 5.0
5.5 Impact Analysis of Drivers and Restraints

6. Europe Smart Life Sciences Manufacturing Market - Europe Analysis

6.1 Overview
6.2 Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)

7. Europe Smart Life Sciences Manufacturing Market Analysis - By Component

7.1 Overview
7.2 Europe Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
7.3 Solutions
- 7.3.1 Overview
- 7.3.2 Solutions: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
- 7.4.1 Overview
- 7.4.2 Services: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

8. Europe Smart Life Sciences Manufacturing Market Analysis - By Technology

8.1 Overview
8.2 Europe Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
8.3 AR/VR System
- 8.3.1 Overview
- 8.3.2 AR/VR System: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.4 Internet of Things (IOT)
- 8.4.1 Overview
- 8.4.2 Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.5 Artificial Intelligence
- 8.5.1 Overview
- 8.5.2 Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.6 Cyber Security
- 8.6.1 Overview
- 8.6.2 Cyber Security: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.7 Big Data
- 8.7.1 Overview
- 8.7.2 Big Data: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

9. Europe Smart Life Sciences Manufacturing Market Analysis - By End Use Industry

9.1 Overview
9.2 Europe Smart Life Sciences Manufacturing Market, by End Use Industry (2022 and 2033)
9.3 Pharma
- 9.3.1 Overview
- 9.3.2 Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.4 Bio-Pharma
- 9.4.1 Overview
- 9.4.2 Bio-Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.5 Medical Device
- 9.5.1 Overview
- 9.5.2 Medical Device: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

10. Europe Smart Life Sciences Manufacturing Market Analysis - By Country

10.1 Europe Smart Life Sciences Manufacturing Market Overview

11. Industry Landscape

11.1 Overview
11.2 Market Initiatives, Expansions, and Strategic Developments
11.3 New Product/Feature Development
11.4 Mergers and Acquisitions
11.5 Agreements, Collaborations, and Joint Ventures

12. Company Profile

12.1 ABB Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bosch Rexroth AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emerson Electric Co
- 12.3.1 Business Description
- 12.3.2 Products and Services
- 12.3.3 Financial Overview
- 12.3.4 SWOT Analysis
- 12.3.5 Key Developments
12.4 Fortinet Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 General Electric Co
- 12.5.1 Business Description
- 12.5.2 Products and Services
- 12.5.3 Financial Overview
- 12.5.4 SWOT Analysis
- 12.5.5 Key Developments
12.6 Honeywell International Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 International Business Machines Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Rockwell Automation Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Siemens AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Sophos Ltd.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Word Index

简介目录图表

List Of Tables

Table 1. Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Table 2. Germany Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 3. Germany Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 4. Germany Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 5. Germany Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 6. France Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 7. France Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 8. France Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 9. France Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 10. Italy Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 11. Italy Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 12. Italy Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 13. Italy Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 14. UK Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 15. UK Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 16. UK Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 17. UK Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 18. Spain Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 19. Spain Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 20. Spain Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 21. Spain Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 22. Rest of Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 23. Rest of Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 24. Rest of Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 25. Rest of Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 26. List of Abbreviation

List Of Figures

Figure 1. Europe Smart Life Sciences Manufacturing Market Segmentation
Figure 2. Europe Smart Life Sciences Manufacturing Market Segmentation, By Country
Figure 3. Europe Smart Life Sciences Manufacturing Market Overview
Figure 4. Solutions Held Largest Share of Component Segment in Europe Smart Life Sciences Manufacturing Market
Figure 5. Europe Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Europe Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 10. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
Figure 11. Solutions: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 12. Services: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 13. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
Figure 14. AR/VR System: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 15. Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 16. Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 17. Cyber Security: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 18. Big Data: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 19. Others: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 20. Europe Smart Life Sciences Manufacturing Market Revenue Share, By End Use Industry (2022 and 2033)
Figure 21. Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 22. Bio-Pharma : Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 23. Medical Device: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 24. Europe Smart Life Sciences Manufacturing Market, by Key Country - Revenue (2022) (US$ Million)
Figure 25. Europe Smart Life Sciences Manufacturing Market, Revenue Share, by Key Country, (2022 & 2033)
Figure 26. Germany: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 27. France: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 28. Italy: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 29. UK: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 30. Spain: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 31. Rest of Europe: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)